RSS-Feed abonnieren
DOI: 10.1055/a-2565-3382
The ABO Blood System and Associated Implications for Hemostasis and Thrombosis

Abstract
The relationship between non-O blood groups and thromboembolic events has been suggested by several studies, although the exact underlying mechanisms are not fully elucidated. However, the correlation between ABO blood groups with the opposite pole of hemostasis, hemorrhage, has been investigated less thoroughly. Non-O blood groups confer an overall increased risk of single, recurrent, and provoked thromboembolic episodes. On the other hand, blood group O has been associated with more severe bleeding events and less favorable manifestations in individuals with hemorrhagic disorders. Therefore, ABO blood group screening may have a role in both thrombotic and hemorrhagic risk assessment and could potentially be added to available clinical prediction systems. This strong belief is supported by the ongoing research. Nevertheless, up to date, the majority of studies represent important heterogeneity, and given the frequency of non-O blood groups, a natural reluctance to incorporate blood groups in risk assessment models arises. Therefore, a more targeted approach should be considered to provide safe outcomes. The in vitro estimation of the thrombotic and hemorrhagic profile of each blood group separately, the quantitative estimation of VWF, FVIII, and platelet function in several disease settings and in well-organized studies, could be useful to establish a clear relationship of ABO blood types with hemostatic and thrombotic disorders. This may ensure a safe approach to categorizing a patient's risk, managing treatment, and influencing prognosis.
Publikationsverlauf
Eingereicht: 10. Januar 2025
Angenommen: 24. März 2025
Artikel online veröffentlicht:
16. April 2025
© 2025. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Farhud DD, Zarif Yeganeh M. A brief history of human blood groups. Iran J Public Health 2013; 42 (01) 1-6
- 2 Dean L. Blood Groups and Red Cell Antigens [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); Accessed 2005. at: https://www.ncbi.nlm.nih.gov/books/NBK2261/L
- 3 Liumbruno GM, Franchini M. Beyond immunohaematology: the role of the ABO blood group in human diseases. Blood Transfus 2013; 11 (04) 491-499
- 4 Franchini M, Liumbruno GM, Lippi G. The prognostic value of ABO blood group in cancer patients. Blood Transfus 2016; 14 (05) 434-440
- 5 Abegaz SB. Human ABO blood groups and their associations with different diseases. BioMed Res Int 2021; 2021: 6629060
- 6 Höglund J, Karlsson T, Johansson T, Ek WE, Johansson Å. Characterization of the human ABO genotypes and their association to common inflammatory and cardiovascular diseases in the UK Biobank. Am J Hematol 2021; 96 (11) 1350-1362
- 7 Jiang F, Liu Z, Zhang Y, Song T. Associations between ABO blood groups and diseases in the digestive system and vein. Int J Gen Med 2024; 17: 1185-1191
- 8 Liu FH, Guo JK, Xing WY. et al. ABO and Rhesus blood groups and multiple health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies. BMC Med 2024; 22 (01) 291
- 9 Franchini M, Mannucci PM. ABO blood group and thrombotic vascular disease. Thromb Haemost 2014; 112 (06) 1103-1109
- 10 Groot HE, Villegas Sierra LE, Said MA, Lipsic E, Karper JC, van der Harst P. Genetically determined ABO blood group and its associations with health and disease. Arterioscler Thromb Vasc Biol 2020; 40 (03) 830-838
- 11 Goumidi L, Thibord F, Wiggins KL. et al. Association between ABO haplotypes and the risk of venous thrombosis: impact on disease risk estimation. Blood 2021; 137 (17) 2394-2402
- 12 Sokou R, Parastatidou S, Konstantinidi A. et al. Contemporary tools for evaluation of hemostasis in neonates. Where are we and where are we headed?. Blood Rev 2024; 64: 101157
- 13 Periayah MH, Halim AS, Mat Saad AZ. Mechanism action of platelets and crucial blood coagulation pathways in hemostasis. Int J Hematol Oncol Stem Cell Res 2017; 11 (04) 319-327
- 14 Lenting PJ, Christophe OD, Denis CV. von Willebrand factor biosynthesis, secretion, and clearance: connecting the far ends. Blood 2015; 125 (13) 2019-2028
- 15 Preston RJ, Rawley O, Gleeson EM, O'Donnell JS. Elucidating the role of carbohydrate determinants in regulating hemostasis: insights and opportunities. Blood 2013; 121 (19) 3801-3810
- 16 Canis K, McKinnon TA, Nowak A. et al. Mapping the N-glycome of human von Willebrand factor. Biochem J 2012; 447 (02) 217-228
- 17 Ruggeri ZM. The role of von Willebrand factor in thrombus formation. Thromb Res 2007; 120 (suppl 1): S5-S9
- 18 Azad A, Akhter Q, Islam M. et al. ABO blood groups and their relationship with coagulation factor VIII in healthy adults. J Biosci Med (Irvine) 2021; 9: 49-58
- 19 Samuelson Bannow B, Recht M, Négrier C. et al. Factor VIII: Long-established role in haemophilia A and emerging evidence beyond haemostasis. Blood Rev 2019; 35: 43-50
- 20 Jenkins PV, O'Donnell JS. ABO blood group determines plasma von Willebrand factor levels: a biologic function after all?. Transfusion 2006; 46 (10) 1836-1844
- 21 Zhou S, Welsby I. Is ABO blood group truly a risk factor for thrombosis and adverse outcomes?. World J Cardiol 2014; 6 (09) 985-992
- 22 O'Donghaile D, Jenkins PV, McGrath RT. et al. Expresser phenotype determines ABO(H) blood group antigen loading on platelets and von Willebrand factor. Sci Rep 2020; 10 (01) 18366
- 23 Dunne E, Qi QM, Shaqfeh ES. et al. Blood group alters platelet binding kinetics to von Willebrand factor and consequently platelet function. Blood 2019; 133 (12) 1371-1377
- 24 Albánez S, Ogiwara K, Michels A. et al. Aging and ABO blood type influence von Willebrand factor and factor VIII levels through interrelated mechanisms. J Thromb Haemost 2016; 14 (05) 953-963
- 25 Akin M, Balkan C, Karapinar DY, Kavakli K. The influence of the ABO blood type on the distribution of von Willebrand factor in healthy children with no bleeding symptoms. Clin Appl Thromb Hemost 2012; 18 (03) 316-319
- 26 Klarmann D, Eggert C, Geisen C. et al. Association of ABO(H) and I blood group system development with von Willebrand factor and Factor VIII plasma levels in children and adolescents. Transfusion 2010; 50 (07) 1571-1580
- 27 Favaloro EJ, Soltani S, McDonald J, Grezchnik E, Easton L, Favaloro JW. Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis. Am J Clin Pathol 2005; 124 (06) 910-917
- 28 Gill JC, Endres-Brooks J, Bauer PJ, Marks Jr WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69 (06) 1691-1695
- 29 Vischer UM, Herrmann FR, Peyrard T, Nzietchueng R, Benetos A. Plasma von Willebrand factor and arterial aging. J Thromb Haemost 2005; 3 (04) 794
- 30 Coppola R, Mari D, Lattuada A, Franceschi C. Von Willebrand factor in Italian centenarians. Haematologica 2003; 88 (01) 39-43
- 31 Mehic D, Hofer S, Jungbauer C. et al. Association of ABO blood group with bleeding severity in patients with bleeding of unknown cause. Blood Adv 2020; 4 (20) 5157-5164
- 32 Mezzano D, Quiroga T. Diagnostic challenges of inherited mild bleeding disorders: a bait for poorly explored clinical and basic research. J Thromb Haemost 2019; 17 (02) 257-270
- 33 Lavin M, Aguila S, Schneppenheim S. et al. Novel insights into the clinical phenotype and pathophysiology underlying low VWF levels. Blood 2017; 130 (21) 2344-2353
- 34 Takayama W, Endo A, Murata K. et al. The impact of blood type on the mortality of patients with severe abdominal trauma: a multicenter observational study. Sci Rep 2021; 11 (01) 16147
- 35 DeBot M, Eitel AP, Moore EE. et al. Blood type O is a risk factor for hyperfibrinolysis and massive transfusion after severe injury. Shock 2022; 58 (06) 492-497
- 36 Follows A, Round A. Impact of ABO blood group on mortality in trauma patients: a systematic review. Transfus Apher Sci 2024; 63 (03) 103925
- 37 Dentali F, Sironi AP, Ageno W. et al. Relationship between ABO blood group and hemorrhage: a systematic literature review and meta-analysis. Semin Thromb Hemost 2013; 39 (01) 72-82
- 38 Jick H, Slone D, Westerholm B. et al. Venous thromboembolic disease and ABO blood type. A cooperative study. Lancet 1969; 1 (7594) 539-542
- 39 Yu M, Wang C, Chen T, Hu S, Yi K, Tan X. ABO blood groups and risk of deep venous thromboembolism in Chinese Han population from Chaoshan region in South China. Saudi Med J 2017; 38 (04) 396-399
- 40 Lima MB, de Oliveira-Filho AB, Campos JF. et al. Increased risk of venous thrombosis by AB alleles of the ABO blood group and Factor V Leiden in a Brazilian population. Genet Mol Biol 2009; 32 (02) 264-267
- 41 Vasan SK, Rostgaard K, Majeed A. et al. ABO blood group and risk of thromboembolic and arterial disease: a study of 1.5 million blood donors. Circulation 2016; 133 (15) 1449-1457 , discussion 1457
- 42 Munsch G, Goumidi L, van Hylckama Vlieg A. et al. Association of ABO blood groups with venous thrombosis recurrence in middle-aged patients: insights from a weighted Cox analysis dedicated to ambispective design. BMC Med Res Methodol 2023; 23 (01) 99
- 43 Dentali F, Franchini M. Recurrent venous thromboembolism: a role for ABO blood group?. Thromb Haemost 2013; 110 (06) 1110-1111
- 44 Limperger V, Kenet G, Kiesau B. et al. Role of prothrombin 19911 A > G polymorphism, blood group and male gender in patients with venous thromboembolism: Results of a German cohort study. J Thromb Thrombolysis 2023; 56 (01) 212
- 45 Gándara E, Kovacs MJ, Kahn SR. et al. Non-OO blood type influences the risk of recurrent venous thromboembolism. A cohort study. Thromb Haemost 2013; 110 (06) 1172-1179
- 46 Baudouy D, Moceri P, Chiche O. et al. B blood group: a strong risk factor for venous thromboembolism recurrence. Thromb Res 2015; 136 (01) 107-111
- 47 Clark P, Wu O. ABO blood groups and thrombosis: a causal association, but is there value in screening?. Future Cardiol 2011; 7 (02) 191-201
- 48 Sode BF, Allin KH, Dahl M, Gyntelberg F, Nordestgaard BG. Risk of venous thromboembolism and myocardial infarction associated with factor V Leiden and prothrombin mutations and blood type. CMAJ 2013; 185 (05) E229-E237
- 49 Spiezia L, Campello E, Bon M. et al. ABO blood groups and the risk of venous thrombosis in patients with inherited thrombophilia. Blood Transfus 2013; 11 (02) 250-253
- 50 Cohen W, Castelli C, Alessi MC. et al. ABO blood group and von Willebrand factor levels partially explained the incomplete penetrance of congenital thrombophilia. Arterioscler Thromb Vasc Biol 2012; 32 (08) 2021-2028
- 51 Bawazir WM. Systematic review and meta-analysis of the susceptibility of ABO blood groups to venous thromboembolism in individuals with factor V Leiden. Diagnostics (Basel) 1936; 2022 (Aug): 11
- 52 Li T, Wang Y, Wu L. et al. The association between ABO blood group and preeclampsia: a systematic review and meta-analysis. Front Cardiovasc Med 2021; 8: 665069
- 53 Hiltunen LM, Laivuori H, Rautanen A. et al. Blood group AB and factor V Leiden as risk factors for pre-eclampsia: a population-based nested case-control study. Thromb Res 2009; 124 (02) 167-173
- 54 Alpoim PN, de Barros Pinheiro M, Junqueira DR. et al. Preeclampsia and ABO blood groups: a systematic review and meta-analysis. Mol Biol Rep 2013; 40 (03) 2253-2261
- 55 Avci D, Karagoz H, Ozer O. et al. Are the blood groups of women with preeclampsia a risk factor for the development of hypertension postpartum?. Ther Clin Risk Manag 2016; 12: 617-622
- 56 Burgess A, Johnson TS, Simanek A, Bell T, Founds S. Maternal ABO blood type and factors associated with preeclampsia subtype. Biol Res Nurs 2019; 21 (03) 264-271
- 57 Lee BK, Zhang Z, Wikman A, Lindqvist PG, Reilly M. ABO and RhD blood groups and gestational hypertensive disorders: a population-based cohort study. BJOG 2012; 119 (10) 1232-1237
- 58 Clark P, Wu O. ABO(H) blood groups and pre-eclampsia. A systematic review and meta-analysis. Thromb Haemost 2008; 100 (03) 469-474
- 59 Aghasadeghi F, Saadat M. Association between ABO and Rh blood groups and risk of preeclampsia: a case-control study from Iran. Open Access Maced J Med Sci 2017; 5 (02) 173-176
- 60 Mahasub N, Boriboonhirunsarn D. Relationship between ABO blood groups and preeclampsia. Hypertens Pregnancy 2020; 39 (03) 348-353
- 61 Okoye HC, Efobi CC, Ugwu AO, Ugwu EO, Nwagha TU. ABO blood group as a biomarker of preeclampsia among antenatal clinic attendees in Nigeria. Niger J Clin Pract 2020; 23 (05) 729-733
- 62 Larsen TB, Johnsen SP, Gislum M, Møller CA, Larsen H, Sørensen HT. ABO blood groups and risk of venous thromboembolism during pregnancy and the puerperium. A population-based, nested case-control study. J Thromb Haemost 2005; 3 (02) 300-304
- 63 Chen Z, Yang SH, Xu H, Li JJ. ABO blood group system and the coronary artery disease: an updated systematic review and meta-analysis. Sci Rep 2016; 6: 23250
- 64 Wu O, Bayoumi N, Vickers MA, Clark P. ABO(H) blood groups and vascular disease: a systematic review and meta-analysis. J Thromb Haemost 2008; 6 (01) 62-69
- 65 Capuzzo E, Bonfanti C, Frattini F. et al. The relationship between ABO blood group and cardiovascular disease: results from the Cardiorisk program. Ann Transl Med 2016; 4 (10) 189
- 66 He M, Wolpin B, Rexrode K. et al. ABO blood group and risk of coronary heart disease in two prospective cohort studies. Arterioscler Thromb Vasc Biol 2012; 32 (09) 2314-2320
- 67 Dentali F, Sironi AP, Ageno W, Crestani S, Franchini M. ABO blood group and vascular disease: an update. Semin Thromb Hemost 2014; 40 (01) 49-59
- 68 Chen Y, Chen C, Ke X. et al. Analysis of circulating cholesterol levels as a mediator of an association between ABO blood group and coronary heart disease. Circ Cardiovasc Genet 2014; 7 (01) 43-48
- 69 Anvari MS, Boroumand MA, Emami B. et al. ABO blood group and coronary artery diseases in iranian patients awaiting coronary artery bypass graft surgery: a review of 10,641 cases. Lab Med 2009; 40: 528-530
- 70 Roest M, Voorbij HA, Barendrecht AD, Peeters PH, van der Schouw YT. Risk of acute ischemic heart disease in postmenopausal women depends on von Willebrand factor and fibrinogen concentrations, and blood group genotype. J Thromb Haemost 2007; 5 (01) 189-191
- 71 Etemadi A, Kamangar F, Islami F. et al. Mortality and cancer in relation to ABO blood group phenotypes in the Golestan cohort study. BMC Med 2015; 13: 8
- 72 Carpeggiani C, Coceani M, Landi P, Michelassi C, L'abbate A. ABO blood group alleles: a risk factor for coronary artery disease. an angiographic study. Atherosclerosis 2010; 211 (02) 461-466
- 73 Ketch TR, Turner SJ, Sacrinty MT. et al. ABO blood types: influence on infarct size, procedural characteristics and prognosis. Thromb Res 2008; 123 (02) 200-205
- 74 Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995; 332 (10) 635-641
- 75 Morange PE, Bezemer I, Saut N. et al. A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. Am J Hum Genet 2010; 86 (04) 592-595
- 76 Heit JA, Armasu SM, Asmann YW. et al. A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost 2012; 10 (08) 1521-1531
- 77 Yamamoto F, McNeill PD, Hakomori S. Human histo-blood group A2 transferase coded by A2 allele, one of the A subtypes, is characterized by a single base deletion in the coding sequence, which results in an additional domain at the carboxyl terminal. Biochem Biophys Res Commun 1992; 187 (01) 366-374
- 78 Chen Z, Dai X, Cao J, Tan X, Chen S, Yu M. Reference intervals for coagulation tests in adults with different ABO blood types. J Clin Lab Anal 2022; 36 (03) e24269
- 79 Choi Q, Kim JE, Kim SY, Han KS, Kim HK. Influence of ABO type on global coagulation assay results: effect of coagulation factor VIII. Clin Chem Lab Med 2015; 53 (09) 1425-1432